Joseph A. Byrne - 19 Apr 2021 Form 3 Insider Report for CEN BIOTECH INC

Role: President, Director
Signature: /s/ Joseph Byrne
Issuer symbol: N/A
Transactions as of: 19 Apr 2021
Net transactions value: $0
Form type: 3
Filing time: 03 Jun 2021, 08:41:02 UTC
Previous filing: 28 May 2021
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CENBF	Common Stock						1,364,894	19 Apr 2021	Direct	F1
holding	CENBF	Common Stock						164,000	19 Apr 2021	By Spouse

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CENBF	Common Stock							19 Apr 2021	Common Stock	76,123	$1.60	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Joseph Byrne (the "Reporting Person") was appointed to his positions with CEN Biotech, Inc. (the "Issuer") on April 19, 2021 and owned 1,362,894 shares of the Issuer's common stock at such date.
F2	The Reporting Person also beneficially owns a convertible note with 76,123 shares issuable upon conversion of same.